Neeli Genetic Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 13.26%
- Profit Growth -37.24%
- Ebitda -32.21%
- Net Worth 49.08%
- Total Assets 132.89%
About Neeli Genetic Services
Neeli Genetic Services Private Limited (NGSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2013 and has a history of 11 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dilip Neeli, Jagadeesh Dindupati, and Deepthi Vankayala serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900TG2013PTC087061
- Company No.
087061
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Neeli Genetic Services?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Neeli  | Director | 18-Apr-2013 | Current |
| Jagadeesh Dindupati | Director | 18-Apr-2013 | Current |
| Deepthi Vankayala | Director | 30-Sep-2022 | Current |
Financial Performance of Neeli Genetic Services.
Neeli Genetic Services Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 13.26% increase. The company also saw a substantial fall in profitability, with a 37.24% decrease in profit. The company's net worth Soared by an impressive increase of 49.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neeli Genetic Services?
In 2019, Neeli Genetic Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neeli Health Care LlpDilip Neeli and Jagadeesh Dindupati are mutual person
- Rgcc India Private Limited
Dilip Neeli is a mutual person
- Eline Life (Opc) Private Limited
Dilip Neeli is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neeli Genetic Services?
Unlock and access historical data on people associated with Neeli Genetic Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neeli Genetic Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neeli Genetic Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.